Sort   by:  
 Page size 
Unknown25 Years of the International Bipolar Collaborative Network (BCN).
Not available
S-EPMC8019011 | biostudies-literature
UnknownWestern Australian medical students' attitudes towards artificial intelligence in healthcare.
Not available
S-EPMC10470885 | biostudies-literature
UnknownThe effects of sodium-glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions.
Not available
S-EPMC6816235 | biostudies-literature
UnknownClinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA.
Not available
S-EPMC8829673 | biostudies-literature
UnknownExploring factors impacting early childhood health among Aboriginal and Torres Strait Islander families and communities: protocol for a population-based cohort study using data linkage (the 'Defying the Odds' study).
Not available
S-EPMC5875609 | biostudies-literature
UnknownAustralasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database.
Not available
S-EPMC7532571 | biostudies-literature
UnknownMechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.
Not available
S-EPMC6302473 | biostudies-literature
UnknownInnovative Telemonitoring Enhanced Care Programme for Chronic Heart Failure (ITEC-CHF) to improve guideline compliance and collaborative care: protocol of a multicentre randomised controlled trial.
Not available
S-EPMC5640081 | biostudies-literature
UnknownPatient-related factors impact the implementation of inpatient antibiotic allergy delabeling.
Not available
S-EPMC11490709 | biostudies-literature
ProteomicsComparative analysis of T cell receptor and chimeric antigen receptor signaling in primary CD8+ T cells
Chimeric antigen receptor-modified (CAR) T cell therapy targeting highly expressed lineage antigens is effective for B cell malignancies. Achieving durable efficacy for hematological malignancies and extending this therapeutic approach to solid tumors will require T cell recognition and elimination ...
ORGANISM(S): Homo sapiens (Human) 
2021-05-20 | PXD013734 | Pride
Chimeric antigen receptor T cell T cell receptor Immunotherapy Phosphoprotein signaling 
Sort   by:  
 Page size